CORC

在结果中检索

CORC

浏览/检索结果: 共16条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
A phase 3 study of durvalumab with or without bevacizumab as adjuvant therapy in patients with hepatocellular carcinoma at high risk of recurrence after curative hepatic resection or ablation: EMERALD-2 会议论文
作者:  Knox, J.;  Cheng, A.;  Cleary, S.;  Galle, P.;  Kokudo, N.
收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study 期刊论文
JOURNAL OF HEPATOLOGY, 2016, 卷号: 65, 期号: 6
作者:  Marrero, Jorge A.;  Kudo, Masatoshi;  Venook, Alan P.;  Ye, Sheng-Long;  Bronowicki, Jean-Pierre
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON 期刊论文
RADIOLOGY, 2016, 卷号: 279, 期号: 2
作者:  Kudo, Masatoshi;  Lencioni, Riccardo;  Heldner, Stephanie;  Lehr, Robert;  Nakajima, Keiko
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05
Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study 期刊论文
LIVER INTERNATIONAL, 2016, 卷号: 36, 期号: 8
作者:  Kudo, Masatoshi;  Lencioni, Riccardo;  Marrero, Jorge A.;  Venook, Alan P.;  Bronowicki, Jean-Pierre
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/06
GIDEON: A RETROSPECTIVE ANALYSIS OF PROGNOSTIC FACTORS FOR SURVIVAL 会议论文
作者:  Bronowicki, J. -P.;  Kudo, M.;  Lencioni, R.;  Chen, X. -P.;  Dagher, L.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis 期刊论文
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 卷号: 68, 期号: 5
作者:  Lencioni, R.;  Kudo, M.;  Ye, S. -L.;  Bronowicki, J. -P.;  Chen, X. -P.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
Final analysis of GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and of its treatment with sorafeNib) in > 3000 sorafenib-treated patients: Prognostic value of baseline characteristics and staging systems 会议论文
作者:  Bronowicki, J.;  Lencioni, R.;  Ye, S. L.;  Kudo, M.;  Papandreou, C.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19
GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA AND OF ITS TREATMENT WITH SORAFENIB) SECOND INTERIM ANALYSIS: CLINICAL FINDINGS IN CHILD-PUGH B SCORE SUBGROUPS 会议论文
作者:  Bronowicki, J. -P.;  Ye, S. -L.;  Kudo, M.;  Marrero, J.;  Dagher, L.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
First interim results of the global investigation of therapeutic decisions in hepatocellular carcinoma (HCC) and of its treatment with sorafenib (GIDEON) study: Use of sorafenib (Sor) by oncologists and nononcologists in the management of HCC 会议论文
作者:  Venook, A. P.;  Lencioni, R.;  Marrero, J. A.;  Kudo, M.;  Nakajima, K.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19
First interim results of the global investigation of therapeutic decisions in hepatocellular carcinoma and of its treatment with sorafenib (GIDEON) study 期刊论文
Annals of Oncology, 2011
作者:  Furuse J., Lencioni R., Lim H.Y., Sta藲l P., Marrero J., Venook A., Nakajima K., Ye S.-L., Kudo M.
收藏  |  浏览/下载：1/0  |  提交时间：2019/12/19

©版权所有 ©2017 CSpace - Powered by CSpace